Global Fragment-based Drug Discovery Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Fragment-based Drug Discovery Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Fragment Screening
  • 1.4.3 Fragment Optimization
• 1.5 Market by Application
  • 1.5.1 Global Fragment-based Drug Discovery Market Share by Application (2014-2025)
  • 1.5.2 Biopharmaceutical Companies
  • 1.5.3 CROs
  • 1.5.4 Academic and Research Institutions
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Fragment-based Drug Discovery Market Size
• 2.2 Fragment-based Drug Discovery Growth Trends by Regions
  • 2.2.1 Fragment-based Drug Discovery Market Size by Regions (2014-2025)
  • 2.2.2 Fragment-based Drug Discovery Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Fragment-based Drug Discovery Market Size by Manufacturers
  • 3.1.1 Global Fragment-based Drug Discovery Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Fragment-based Drug Discovery Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Fragment-based Drug Discovery Market Concentration Ratio (CR5 and HHI)
• 3.2 Fragment-based Drug Discovery Key Players Head office and Area Served
• 3.3 Key Players Fragment-based Drug Discovery Product/Solution/Service
• 3.4 Date of Enter into Fragment-based Drug Discovery Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Fragment-based Drug Discovery Market Size by Type (2014-2019)
• 4.2 Global Fragment-based Drug Discovery Market Size by Application (2014-2019)

5 United States

• 5.1 United States Fragment-based Drug Discovery Market Size (2014-2019)
• 5.2 Fragment-based Drug Discovery Key Players in United States
• 5.3 United States Fragment-based Drug Discovery Market Size by Type
• 5.4 United States Fragment-based Drug Discovery Market Size by Application

6 Europe

• 6.1 Europe Fragment-based Drug Discovery Market Size (2014-2019)
• 6.2 Fragment-based Drug Discovery Key Players in Europe
• 6.3 Europe Fragment-based Drug Discovery Market Size by Type
• 6.4 Europe Fragment-based Drug Discovery Market Size by Application

7 China

• 7.1 China Fragment-based Drug Discovery Market Size (2014-2019)
• 7.2 Fragment-based Drug Discovery Key Players in China
• 7.3 China Fragment-based Drug Discovery Market Size by Type
• 7.4 China Fragment-based Drug Discovery Market Size by Application

8 Japan

• 8.1 Japan Fragment-based Drug Discovery Market Size (2014-2019)
• 8.2 Fragment-based Drug Discovery Key Players in Japan
• 8.3 Japan Fragment-based Drug Discovery Market Size by Type
• 8.4 Japan Fragment-based Drug Discovery Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Fragment-based Drug Discovery Market Size (2014-2019)
• 9.2 Fragment-based Drug Discovery Key Players in Southeast Asia
• 9.3 Southeast Asia Fragment-based Drug Discovery Market Size by Type
• 9.4 Southeast Asia Fragment-based Drug Discovery Market Size by Application

10 India

• 10.1 India Fragment-based Drug Discovery Market Size (2014-2019)
• 10.2 Fragment-based Drug Discovery Key Players in India
• 10.3 India Fragment-based Drug Discovery Market Size by Type
• 10.4 India Fragment-based Drug Discovery Market Size by Application

11 Central & South America

• 11.1 Central & South America Fragment-based Drug Discovery Market Size (2014-2019)
• 11.2 Fragment-based Drug Discovery Key Players in Central & South America
• 11.3 Central & South America Fragment-based Drug Discovery Market Size by Type
• 11.4 Central & South America Fragment-based Drug Discovery Market Size by Application

12 International Players Profiles

• 12.1 Astex Pharmaceuticals
  • 12.1.1 Astex Pharmaceuticals Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Fragment-based Drug Discovery Introduction
  • 12.1.4 Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2014-2019)
  • 12.1.5 Astex Pharmaceuticals Recent Development
• 12.2 Alveus Pharmaceuticals
  • 12.2.1 Alveus Pharmaceuticals Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Fragment-based Drug Discovery Introduction
  • 12.2.4 Alveus Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2014-2019)
  • 12.2.5 Alveus Pharmaceuticals Recent Development
• 12.3 Beactica
  • 12.3.1 Beactica Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Fragment-based Drug Discovery Introduction
  • 12.3.4 Beactica Revenue in Fragment-based Drug Discovery Business (2014-2019)
  • 12.3.5 Beactica Recent Development
• 12.4 Charles River Laboratories
  • 12.4.1 Charles River Laboratories Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Fragment-based Drug Discovery Introduction
  • 12.4.4 Charles River Laboratories Revenue in Fragment-based Drug Discovery Business (2014-2019)
  • 12.4.5 Charles River Laboratories Recent Development
• 12.5 Crown Bioscience
  • 12.5.1 Crown Bioscience Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Fragment-based Drug Discovery Introduction
  • 12.5.4 Crown Bioscience Revenue in Fragment-based Drug Discovery Business (2014-2019)
  • 12.5.5 Crown Bioscience Recent Development
• 12.6 Emerald BioStructures
  • 12.6.1 Emerald BioStructures Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Fragment-based Drug Discovery Introduction
  • 12.6.4 Emerald BioStructures Revenue in Fragment-based Drug Discovery Business (2014-2019)
  • 12.6.5 Emerald BioStructures Recent Development
• 12.7 Evotec
  • 12.7.1 Evotec Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Fragment-based Drug Discovery Introduction
  • 12.7.4 Evotec Revenue in Fragment-based Drug Discovery Business (2014-2019)
  • 12.7.5 Evotec Recent Development
• 12.8 Kinetic Discovery
  • 12.8.1 Kinetic Discovery Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Fragment-based Drug Discovery Introduction
  • 12.8.4 Kinetic Discovery Revenue in Fragment-based Drug Discovery Business (2014-2019)
  • 12.8.5 Kinetic Discovery Recent Development
• 12.9 Proteros Fragments
  • 12.9.1 Proteros Fragments Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Fragment-based Drug Discovery Introduction
  • 12.9.4 Proteros Fragments Revenue in Fragment-based Drug Discovery Business (2014-2019)
  • 12.9.5 Proteros Fragments Recent Development
• 12.10 Sprint Bioscience
  • 12.10.1 Sprint Bioscience Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Fragment-based Drug Discovery Introduction
  • 12.10.4 Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2014-2019)
  • 12.10.5 Sprint Bioscience Recent Development
• 12.11 Structure Based Design
• 12.12 Sygnature Discovery

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer